These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15359582)

  • 21. Development of an in vivo preclinical screen model to estimate absorption and first-pass hepatic extraction of xenobiotics. II. Use of ketoconazole to identify P-glycoprotein/CYP3A-limited bioavailability in the monkey.
    Ward KW; Stelman GJ; Morgan JA; Zeigler KS; Azzarano LM; Kehler JR; McSurdy-Freed JE; Proksch JW; Smith BR
    Drug Metab Dispos; 2004 Feb; 32(2):172-7. PubMed ID: 14744938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of propranolol and atenolol in patients after partial gastric resection: a comparative study.
    Wójcicki J; Wojciechowski G; Wójcicki M; Kostyrka R; Sterna R; Gawronska-Szklarz B; Pawlik A; Drozdzik M; Kozlowski K
    Eur J Clin Pharmacol; 2000 Apr; 56(1):75-9. PubMed ID: 10853882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of 1-aminobenzotriazole in differentiating the role of CYP-mediated first pass metabolism and absorption in limiting drug oral bioavailability: a case study.
    El-Kattan AF; Poe J; Buchholz L; Thomas HV; Brodfuehrer J; Clark A
    Drug Metab Lett; 2008 Apr; 2(2):120-4. PubMed ID: 19356080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors limiting the oral bioavailability of N-acetylglucosaminyl-N-acetylmuramyl dipeptide (GMDP) and enhancement of absorption in rats by delivery in a water-in-oil microemulsion.
    Lyons KC; Charman WN; Miller R; Porter CJ
    Int J Pharm; 2000 Apr; 199(1):17-28. PubMed ID: 10794923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats hepatic and intestinal first-pass effects.
    Kim SH; Lee MG
    Life Sci; 2002 Feb; 70(11):1299-315. PubMed ID: 11883708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
    Kharasch ED; Walker A; Hoffer C; Sheffels P
    Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of intestinal availability of various drugs in the oral absorption process using portal vein-cannulated rats.
    Matsuda Y; Konno Y; Satsukawa M; Kobayashi T; Takimoto Y; Morisaki K; Yamashita S
    Drug Metab Dispos; 2012 Dec; 40(12):2231-8. PubMed ID: 22930277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence of significant absorption of antipyrine from urinary bladder of rats.
    Dalton JT; Harrington MD; Au JL
    J Pharmacol Exp Ther; 1992 Feb; 260(2):608-13. PubMed ID: 1738110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of administration route on the biotransformation of amoxicillin in the pig.
    Reyns T; De Boever S; Schauvliege S; Gasthuys F; Meissonnier G; Oswald I; De Backer P; Croubels S
    J Vet Pharmacol Ther; 2009 Jun; 32(3):241-8. PubMed ID: 19646088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis and prediction of absorption profile including hepatic first-pass metabolism of N-methyltyramine, a potent stimulant of gastrin release present in beer, after oral ingestion in rats by gastrointestinal-transit-absorption model.
    Kimura T; Iwasaki N; Yokoe JI; Haruta S; Yokoo Y; Ogawara KI; Higaki K
    Drug Metab Dispos; 2000 May; 28(5):577-81. PubMed ID: 10772638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osmolality of Orally Administered Solutions Influences Luminal Water Volume and Drug Absorption in Intestine.
    Ichijo K; Oda R; Ishihara M; Okada R; Moteki Y; Funai Y; Horiuchi T; Kishimoto H; Shirasaka Y; Inoue K
    J Pharm Sci; 2017 Sep; 106(9):2889-2894. PubMed ID: 28450238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of permanent cannulation of the jugular vein on pharmacokinetics of amoxycillin and antipyrine in the rat.
    Torres-Molina F; Aristorena JC; Garcia-Carbonell C; Granero L; Chesa-Jiménez J; Pla-Delfina J; Peris-Ribera JE
    Pharm Res; 1992 Dec; 9(12):1587-91. PubMed ID: 1488402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absorption, first-pass metabolism, and disposition of itraconazole in rats.
    Yoo SD; Kang E; Jun H; Shin BS; Lee KC; Lee KH
    Chem Pharm Bull (Tokyo); 2000 Jun; 48(6):798-801. PubMed ID: 10866139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats.
    Liu YT; Hao HP; Xie HG; Lai L; Wang Q; Liu CX; Wang GJ
    Drug Metab Dispos; 2010 Oct; 38(10):1779-84. PubMed ID: 20634337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
    Shim HJ; Kim YC; Park KJ; Kim DS; Kwon JW; Kim WB; Lee MG
    J Pharm Sci; 2003 Nov; 92(11):2185-95. PubMed ID: 14603504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and first-pass elimination of metoprolol in rats: contribution of intestinal first-pass extraction to low bioavailability of metoprolol.
    Yoon IS; Choi MK; Kim JS; Shim CK; Chung SJ; Kim DD
    Xenobiotica; 2011 Mar; 41(3):243-51. PubMed ID: 21128757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigating the barriers to bioavailability of macrolide antibiotics in the rat.
    Padovan J; Ralić J; Letfus V; Milić A; Bencetić Mihaljević V
    Eur J Drug Metab Pharmacokinet; 2012 Sep; 37(3):163-71. PubMed ID: 22113743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Saturable first-pass kinetics of propranolol.
    Keller F; Kunzendorf U; Walz G; Haller H; Offermann G
    J Clin Pharmacol; 1989 Mar; 29(3):240-5. PubMed ID: 2723110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alteration of the pharmacokinetics and metabolism of propranolol and antipyrine elicited by indwelling catheters in the rat.
    Chindavijak B; Belpaire FM; De Smet F; Bogaert MG
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1075-9. PubMed ID: 3418510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.